Insilico Medicine, a Baltimore-based next-generation artificial intelligence company specialized in the application of d...
Zai Lab, a Shanghai-based innovative biopharmaceutical company, recently announced that Mr William Liang has b...
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...
GE Healthcare will provide China-based Xiangxue Pharmaceutical (XPH) with a FlexFactory for cell therapy. The system, ex...
Oncologie, an innovative biopharmaceutical company, recently announced that it is launching operations in both Boston an...
A group of researchers from Chinese Academy of Sciences and Peking University Third Hospital has developed a new type of...
China has approved the first domestically developed, long-acting injectable HIV drug Albuvirtide, which could be a boon ...
Singapore- Wize Pharma, a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorder...
Ally Bridge Group (ABG), a China-centered healthcare investor, has completed a Series A investment, as the first part of...
P-MEC China will be held at the Shanghai New International Expo Center (SNIEC), Shanghai, China, from 20-22 Ju...
Singapore- Blueprint Medicines and CStone Pharmaceuticals, a privately-held biopharmaceutical company announce an e...
Xynomic Pharma, a clinical stage US-China oncology drug development company, recently announced that it has complete...
SenseTime Group has raised $620 million at a valuation of more than $4.5 billion just months after scoring a similar amo...
Gilead Sciences, Inc. has announced that the China Drug Administration (CDA) has approved Epclusa for the treatment of a...
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...
Chinese e-commerce giant Alibaba Group Holding Ltd will inject some of its online pharmacy business into a listed unit i...
Shuwen Biotech Co. Ltd., an emerging leader in innovative diagnostic products and services has signed a partnership agre...
Luye Pharma Group recently announced their acquisition of AstraZeneca's core CNS products - Seroquel and Seroquel XR. As...